IGC Pharma, Inc. (IGC) Form 8-K — Jul 6, 2026
IGC Pharma entered into Stock Purchase Agreements with CEO Ram Mukunda and VP/PFO Claudia Grimaldi to issue common stock in exchange for cancelling outstanding debts owed to them. The company issued 2,226,475 shares to Mr. Mukunda and 2,048,378 shares to Ms. Grimaldi at a price of $0.27 per share.
Key figures
- Offering Price
- 0.27
- Mukunda shares
- 2226475
- Grimaldi shares
- 2048378
- Total debt reduced
- 1154210
- Mukunda debt cancelled
- 601148
- Grimaldi debt cancelled
- 553062
Price after filing
1 day: -1.1%7 days: -5.4%30 days: -11.7%
Close on the filing date to close N calendar days later (from $0.28). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.